Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1965 Apr;102(4):310–313.

Quinidine-Induced Thrombocytopenic Purpura

E Conway Stratford Jr, Kouichi R Tanaka
PMCID: PMC1515752  PMID: 14288151

Full text

PDF
310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACKROYD J. F. Allergic purpura, including purpura due to foods, drugs and infections. Am J Med. 1953 May;14(5):605–632. doi: 10.1016/0002-9343(53)90377-5. [DOI] [PubMed] [Google Scholar]
  2. ACKROYD J. F. The cause of thrombocytopenia in sedormid purpura. Clin Sci. 1949 Dec 19;8(4):269-89, incl pl. [PubMed] [Google Scholar]
  3. ACKROYD J. F. The mechanism of the reduction of clot retraction by sedormid in the blood of patients who have recovered from sedormid purpura. Clin Sci. 1949 Dec 19;8(4):235-67, incl 3 pl. [PubMed] [Google Scholar]
  4. BERGER H. Cause of drug-induced thrombocytopenic purpura identified by the passive transfer reaction. Ann Intern Med. 1962 Apr;56:618–623. doi: 10.7326/0003-4819-56-4-618. [DOI] [PubMed] [Google Scholar]
  5. BETTMAN J. W., Jr DRUG HYPERSENSITIVITY PURPURAS. REPORT OF A CASE AND DISCUSSION OF THEIR MECHANISMS. Arch Intern Med. 1963 Dec;112:840–845. doi: 10.1001/archinte.1963.03860060078007. [DOI] [PubMed] [Google Scholar]
  6. BOLTON F. G., DAMESHEK W. Thrombocytopenic purpura due to quinidine. I. Clinical studies. Blood. 1956 Jun;11(6):527–546. [PubMed] [Google Scholar]
  7. FREEDMAN A. L., BRODY E. A., BARR P. S. Immunothrombocytopenic purpura due to quinidine; report of four new cases with special observations on patch testing. J Lab Clin Med. 1956 Aug;48(2):205–217. [PubMed] [Google Scholar]
  8. SCHEN R. J., RABINOVITZ M. Thrombocytopenic purpura due to quinidine. Br Med J. 1958 Dec 20;2(5111):1502–1505. doi: 10.1136/bmj.2.5111.1502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. SHULMAN N. R. Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex. J Exp Med. 1958 May 1;107(5):665–690. doi: 10.1084/jem.107.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SHULMAN N. R. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura. J Exp Med. 1958 May 1;107(5):697–710. doi: 10.1084/jem.107.5.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SHULMAN N. R. Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura. J Exp Med. 1958 May 1;107(5):711–729. doi: 10.1084/jem.107.5.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WEINTRAUB R. M., PECHET L., ALEXANDER B. Rapid diagnosis of drug-induced thrombocytopenic purpura. Report of three cases due to quinine, quinidine, and Dilantin. JAMA. 1962 May 19;180:528–532. doi: 10.1001/jama.1962.03050200012004. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES